WOBURN, MA / ACCESSWIRE / May 6, 2024 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will report financial results for the three months ended March 29, 2024 on Wednesday, May 15, 2024. The results will be released after the market close on Wednesday, May 15 and the company will host a conference call on Thursday, May 16 at 10:00am Eastern Time.
Conference Call and Webcast Information
| Toll Free | 1-877-877-1275 |
| International | 1-412-858-5202 |
| Webcast | Webcast | Biofrontera Inc. First Quarter 2024 Financial Results and Business Update Conference Call (choruscall.com) |
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.
Contacts:
Investor Relations
Andrew Barwicki
1-516-662-9461
ir@bfri.com
SOURCE: Biofrontera Inc.
View the original press release on accesswire.com
PARIS, FRANCE / ACCESS Newswire / December 16, 2025 / One year after deploying CaloPix®,…
PARIS, FRANCE / ACCESS Newswire / December 16, 2025 / One year after deploying CaloPix®,…
PARIS, FRANCE / ACCESS Newswire / December 16, 2025 / One year after deploying CaloPix®,…
A Look Back at Key Milestones and Successes Achieved in 2025What's Ahead: Exciting Plans, Strategic…
A Look Back at Key Milestones and Successes Achieved in 2025What's Ahead: Exciting Plans, Strategic…
A Look Back at Key Milestones and Successes Achieved in 2025What's Ahead: Exciting Plans, Strategic…